The differences between batch processing and continuous manufacturing of biologics require a detailed understanding of material traceability and the effects of perturbations on material quality.
As the industry moves toward continuous bioprocessing, more effective ways are being developed to validate viral clearance. Researchers at Asahi Kasei Bioprocess America have developed a small-scale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results